이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - tamsulosina cloridrato - capsule - "0,4 mg capsule rigide a rilascio modificato" 20 capsule in blister pvc/pe/pvdc/al - farmaci per l'ipertrofia prostatica - farmaci per l'ipertrofia prostatica

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - dutasteridum, tamsulosini hydrochloridum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: glyceroli monocaprylocapras, e 321, gelatina, glycerolum 64.2 mg, aqua purificata, e 171, e 172 (flavum), triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: cellulosum microcristallinum, magnesii stearas, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum corresp. natrium 0.05 mg, triacetinum, e 171, talcum, kapselhülle: hypromellosum, kalii chloridum, carrageenanum, e 171, e 110 0.06 mg, e 172 (rubrum), aqua purificata, pro capsula. - iperplasia prostatica benigna - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - dutasteridum, tamsulosini hydrochloridum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, e 171, glycerolum, triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - tamsulosin and solifenacin - tamsulosin and solifenacin

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, hypromellosum, cellulosum microcristallinum, carbomerum, silica colloidalis anhydrica, magnesii stearas, e 172 (rubrum), pro compresso obducto. - iperplasia prostatica benigna - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - tamsulosinum - retardkapseln - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 30 µg, triethylis citras, talcum, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), e 132 pro capsula. - iperplasia prostatica benigna - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - tamsulosinum - retardkapseln - tamsulosini hydrochloridum 0,4 mg corrisp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici e ethylis acrylatis polymerisati 1:1 dispersio 30 per cento con polysorbatum 80 e natrii laurilsulfas corrisp. sodio 7.28 µg, triethylis citras, talco, kapselhülle: gelatina, e 132, e 171, e 172 (rosso) e 172 (giallo) e 172 (nero) per la capsula. - iperplasia prostatica benigna - synthetika

스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.376 mg, hypromellosum, cellulosum microcristallinum, carbomerum, silica colloidalis anhydrica, magnesii stearas, e 172 (rubrum), pro compresso. - iperplasia prostatica benigna - synthetika

이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

aurobindo pharma italia srl - tamsulosina cloridrato - capsule - "0,4 mg capsule rigide a rilascio prolungato" 20 capsule in blister pvc/pvdc/al - farmaci per l'ipertrofia prostatica - farmaci per l'ipertrofia prostatica

이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

ecupharma s.r.l. - tamsulosin and solifenacin - tamsulosin and solifenacin